Attached files

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported) May 18, 2012


                                GURU HEALTH INC.
             (Exact name of registrant as specified in its charter)

           Nevada                     000-54522                   27-1833279
(State or other jurisdiction         (Commission                (IRS Employer
      of incorporation)              File Number)            Identification No.)

    #10 - 1019 17th SW, Calgary, AB                                T2T 0A7
(Address of principal executive offices)                          (Zip Code)

                                 (403) 612-4130
              (Registrant's telephone number, including area code)

                                       n/a
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))

ITEM 1.01 ENTRY INTO MATERIAL DEFINITIVE AGREEMENT

ITEM 2.03 CREATION OF A DIRECT  FINANCIAL  OBLIGATION OR AN OBLIGATION  UNDER AN
          OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

On May 18,  2012,  Guru  Health  Inc.  (the  "Company",  "we",  "us")  issued  a
convertible debenture in the amount of $125,000 to one investor. The convertible
debenture  carries an interest rate of 10% per annum, is due on May 18, 2014 and
is convertible at the investor's  discretion  into shares of our common stock at
$0.50 per share.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

10.1      Form of Convertible Debenture

                                       2

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

GURU HEALTH INC.


/s/ Matthew Christopherson
---------------------------------------------
Matthew Christopherson
President and Director

Date: May 29, 2012